Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $40 | $54 | $103 | $161 |
| Short-Term Investments | $145 | $23 | $0 | $0 |
| Receivables | $0 | $2 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $1 | $2 | $1 |
| Total Curr. Assets | $189 | $80 | $105 | $162 |
| Property Plant & Equip (Net) | $20 | $25 | $28 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $4 |
| Total NC Assets | $21 | $25 | $28 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $210 | $105 | $133 | $170 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $4 | $4 | $3 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $11 | $7 |
| Other Curr. Liab. | $7 | $8 | $10 | $10 |
| Total Curr. Liab. | $12 | $12 | $26 | $19 |
| LT Debt | $11 | $13 | $16 | $1 |
| Deferred Rev, NC | $0 | $0 | $16 | $22 |
| Deferred Tax Liab, NC | $0 | $0 | $216 | $216 |
| Other NC Liab. | $0 | $242 | $0 | $0 |
| Total NC Liab. | $11 | $255 | $248 | $239 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $14 | $17 | $19 | $2 |
| Total Liabilities | $23 | $267 | $274 | $259 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$247 | -$181 | -$153 | -$94 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $433 | $19 | $12 | $5 |
| Total Equity | $187 | -$162 | -$141 | -$89 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $210 | $105 | $133 | $170 |
| Net Debt | -$26 | -$37 | -$83 | -$159 |